Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide.
about
RIP140 directs histone and DNA methylation to silence Ucp1 expression in white adipocytesDnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcriptionA phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genesDNA demethylation and invasive cancer: implications for therapeuticsMethylation-dependent gene silencing induced by interleukin 1beta via nitric oxide productionThe DNMT1 target recognition domain resides in the N terminus.DNA methyltransferases: a novel target for prevention and therapy.P15INK4b gene methylation and myelodysplastic syndromes.DNA methylation and cancer.Reduced rates of gene loss, gene silencing, and gene mutation in Dnmt1-deficient embryonic stem cells.Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin.DNA methylation, chromatin inheritance, and cancer.Laccaic acid A is a direct, DNA-competitive inhibitor of DNA methyltransferase 1.DNA methylation in genomic imprinting, development, and disease.Methylation and colorectal cancer.Synergistic effects of combined DNA methyltransferase inhibition and MBD2 depletion on breast cancer cells; MBD2 depletion blocks 5-aza-2'-deoxycytidine-triggered invasivenessSuppression of TET1-dependent DNA demethylation is essential for KRAS-mediated transformation.Beyond Watson and Crick: DNA methylation and molecular enzymology of DNA methyltransferases.6-Thioguanine reactivates epigenetically silenced genes in acute lymphoblastic leukemia cells by facilitating proteasome-mediated degradation of DNMT1Derepression of Cancer/testis antigens in cancer is associated with distinct patterns of DNA hypomethylation.Epigenetic cancer therapies: DNA methyltransferase inhibitors.Mallory-Denk Body (MDB) formation modulates Ufmylation expression epigenetically in alcoholic hepatitis (AH) and non-alcoholic steatohepatitis (NASH).DNA demethylating antineoplastic strategies: a comparative point of viewReduction of pancreatic acinar cell tumor multiplicity in Dnmt1 hypomorphic mice.An ultrasensitive high throughput screen for DNA methyltransferase 1-targeted molecular probesCHST11 gene expression and DNA methylation in breast cancerMechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1.AUF1 cell cycle variations define genomic DNA methylation by regulation of DNMT1 mRNA stabilityDemethylation of DNA by decitabine in cancer chemotherapy.RFTS-deleted DNMT1 enhances tumorigenicity with focal hypermethylation and global hypomethylationTherapeutic implications of DNA methylation.Pharmacological inhibition of DNA methylation induces proinvasive and prometastatic genes in vitro and in vivo.DNA methyltransferase inhibitors in acute myeloid leukemia: discovery, design and first therapeutic experiences.Modified oligonucleotides as bona fide antagonists of proteins interacting with DNA. Hairpin antagonists of the human DNA methyltransferase.Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis.DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation.A potent cell-active allosteric inhibitor of murine DNA cytosine C5 methyltransferase.CRL4B promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3A in DNA methylation-based epigenetic silencing.DNA methyltransferase 1 knockdown activates a replication stress checkpoint.Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.
P2860
Q24299066-6B14C1F7-DC58-4F2B-AB85-35DF9C8B4A5BQ24534441-F78FACBA-716A-4248-A32A-B66D1D8A730BQ24804876-CC82F7C5-4931-47BA-84D8-3CF89EDD8841Q27011914-92EE3A8E-662B-4F5B-9C63-44D74FAA649DQ28577262-44EA66BA-9D9E-4AF7-B041-6643BDCDF0B2Q31650618-02029CC7-15A3-4F9A-883D-0552F7AA4F0AQ33579896-4B8A2C35-B4DA-4A55-BDD7-B6E7D7AEFB06Q33803233-D3EBFA28-2335-48AA-BCEC-11D83097637EQ33875819-4E923A71-356C-4E18-8354-B7EBF785F1F4Q34012712-F3905169-DB6B-430E-ADE0-A7DCBBE1BDD1Q34276683-B4C36176-4969-4152-B9D4-E70D1A6F34DFQ34290318-753E2A86-E935-47E9-94BF-E4A419B19CD2Q34356422-641E72A1-C783-43C4-ABC7-EFD51EC8D386Q34378421-7457D531-1830-4A68-8399-A94DD440726EQ34378429-E9D11E64-EFC6-48EC-B1B5-96B8718EB617Q34434924-DC9F59D1-5791-4CC7-8410-22172A6728F7Q34451594-1E869E1C-7979-4C6D-9F68-FF55871A413CQ34587622-95697313-99F1-4E4F-8B78-28B7FB58861BQ34629933-225F6A39-7C91-4B1C-A2D2-B23FA8D96592Q34632716-C9342E52-4375-4293-82C0-42AECA86E274Q34660829-8837C662-38D3-4E10-9FC3-627418C87300Q34674178-621974EE-56D6-4368-9B59-0DA986FCC3B7Q34972245-63643F4C-35E6-470B-B891-B5364DE8DDCCQ35020444-B462A01A-0832-4747-91F3-EE7A65D79BA4Q35043571-535580DF-7B65-4F52-ADA6-8B6AFFCE530AQ35073326-4AFFA03E-D713-4406-AEB8-CA41C44C9D2EQ35619996-4022B4F3-B4F6-4229-A697-D0096DED4D8BQ35641715-3C1E7F5F-6AC1-4347-B7A2-B0E6658BDEF1Q35843658-883EE723-FED1-4DEE-A458-2FA4B1A0FFD5Q36189555-776F1BE7-8F02-482F-8AD1-3F34B976FE49Q36429409-E82C5EFC-8D16-4D43-B429-F82653C75BA0Q36485293-477157C9-2E09-4628-8E48-7728BC9764EAQ38040883-242668F7-A268-4B9F-B991-A813D99314D0Q38328254-10AA9A31-A18E-4BDF-BC09-123E2441504BQ38341003-AFB09175-27B2-4296-A668-2C02439FE2F5Q38342368-3BCFBE39-A360-4D52-9CCA-B7DBD387D322Q38359862-086621FE-F761-43EC-804E-352E06CACF99Q39051578-418FFCD2-035A-4207-B0A2-FF164B3CAE7BQ39129505-E9388506-4BBE-4DA1-AAC0-65681B56A031Q39561459-70AD01C1-D92D-4417-966D-C1D5F1C43B1D
P2860
Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Inhibition of tumorigenesis by ...... ntisense oligodeoxynucleotide.
@ast
Inhibition of tumorigenesis by ...... ntisense oligodeoxynucleotide.
@en
type
label
Inhibition of tumorigenesis by ...... ntisense oligodeoxynucleotide.
@ast
Inhibition of tumorigenesis by ...... ntisense oligodeoxynucleotide.
@en
prefLabel
Inhibition of tumorigenesis by ...... ntisense oligodeoxynucleotide.
@ast
Inhibition of tumorigenesis by ...... ntisense oligodeoxynucleotide.
@en
P2093
P2860
P356
P1476
Inhibition of tumorigenesis by ...... ntisense oligodeoxynucleotide.
@en
P2093
P2860
P304
P356
10.1073/PNAS.94.2.684
P407
P577
1997-01-01T00:00:00Z